Testing effectiveness (Phase 2)Study completedNCT02302066
What this trial is testing
Safety and Immunogenicity of Different Schedules of Takeda's Tetravalent Dengue Vaccine Candidate (TDV) in Healthy Participants
Who this might be right for
Dengue Fever
Takeda 1,800